Exploring the Potential of Breast Microbiota as Biomarker for Breast Cancer and Therapeutic Response

Breast microbiota holds many possibilities to reveal more insight into the pathophysiology of breast cancer. Using the breast microbiome as a marker to predict breast cancer prognosis and therapeutic response holds promise. Targeting microbiota could be used to improve therapeutic efficiency and reduce related toxicity. Before breast microbiota analysis can be implemented, major knowledge gaps need to be considered. There is limited understanding of the contribution of breast microbiota to cancer development and treatment response. Because indications exist that breast microbiota components interact with the gut microbiota and the immune system, these need to be explored in parallel.